SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Levine Mark) srt2:(2010-2014)"

Sökning: WFRF:(Levine Mark) > (2010-2014)

  • Resultat 11-16 av 16
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
11.
  •  
12.
  • Levine, Mark, et al. (författare)
  • The solution for Israelis and Palestinians: a parallel state structure
  • 2010
  • Ingår i: Christian Science Monitor.
  • Tidskriftsartikel (populärvet., debatt m.m.)abstract
    • Growing US-Israeli tension over continued East Jerusalem settlement construction – which the White House appears unable to stop – underscores a deeper reality: The two-state solution is no longer possible. What are the alternatives? For the past few years, the idea of a “parallel states” structure has been discussed, suggesting a scenario with a two-states structure on the same land, both states covering the whole territory, both providing the freedom for their citizens – Israelis and Palestinians – to live between the Mediterranean Sea and the Jordan River.
  •  
13.
  •  
14.
  •  
15.
  •  
16.
  • Teo, Koon K., et al. (författare)
  • Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
  • 2011
  • Ingår i: Journal of Hypertension. - 0263-6352 .- 1473-5598. ; 29:4, s. 623-635
  • Forskningsöversikt (refereegranskat)abstract
    • Background Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) reduce cardiovascular disease (CVD) events, but a recent meta-analysis of selected studies suggested that ARBs may increase cancer risks.Objective Candesartan, irbesartan, telmisartan, valsartan, and losartan were assessed for incident cancers in 15 large parallel long-term multicenter double-blind clinical trials of these agents involving 138 769 participants.Patients and methods Individuals at high CVD risk were randomized to telmisartan (three trials, n=51 878), irbesartan (three trials, n=14 859), valsartan (four trials, n=44 264), candesartan (four trials, n=18 566), and losartan (one trial, n=9193) and followed for 23-60 months. Incident cancer cases were compared in patients randomized to ARBs versus controls. In five trials (n=42 403), the ARBs were compared to ACEi and in 11 trials (n=63 313) to controls without ACEi. In addition, in seven trials (n=47 020), the effect of ARBs with ACEi was compared to ACEi alone and in two trials ARBs with ACEi versus ARB alone (n=25 712).Results Overall, there was no excess of cancer incidence with ARB therapy compared to controls in the 15 trials [ 4549 (6.16%) cases of 73 808 allocated to ARB versus 3856 (6.31%) of 61 106 assigned to non-ARB controls; odds ratio (OR) 1.00, 95% confidence interval (CI) 0.95-1.04] overall or when individual ARBs were examined. ORs comparing combination therapy with ARB along with ACEi versus ACEi was 1.01 (95% CI 0.94-1.10), combination versus ARB alone 1.02 (95% CI 0.91-1.13), ARB alone versus ACEi alone 1.06 (95% CI 0.97-1.16) and ARB versus placebo/control without ACEi 0.97 (95% CI 0.91-1.04). There was no excess of lung, prostate or breast cancer, or overall cancer deaths associated with ARB treatment.Conclusion There was no significant increase in the overall or site-specific cancer risk from ARBs compared to controls.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 11-16 av 16
Typ av publikation
tidskriftsartikel (9)
forskningsöversikt (3)
samlingsverk (redaktörskap) (2)
bokkapitel (2)
Typ av innehåll
refereegranskat (11)
populärvet., debatt m.m. (3)
övrigt vetenskapligt/konstnärligt (2)
Författare/redaktör
Chanock, Stephen J (2)
Yang, Yang (1)
Olsson, Håkan (1)
Davies, Gareth (1)
Wang, Jin (1)
Wang, Kai (1)
visa fler...
Wang, Mei (1)
Swedberg, Karl, 1944 (1)
Jörnsten, Rebecka, 1 ... (1)
Weber, Michael (1)
Kling, Teresia, 1985 (1)
Sánchez, José, 1979 (1)
Nelander, Sven, 1974 (1)
Strålfors, Peter (1)
Kominami, Eiki (1)
Salvesen, Guy (1)
Bonaldo, Paolo (1)
Halfvarson, Jonas, 1 ... (1)
Minucci, Saverio (1)
McMurray, John J. V. (1)
Ibsen, Hans (1)
Deloukas, Panos (1)
De Milito, Angelo (1)
Zhang, Wei (1)
Agholme, Lotta (1)
Kågedal, Katarina (1)
Wu, Anna H. (1)
Durbeej-Hjalt, Madel ... (1)
Liu, Wei (1)
Chen, Xi (1)
Siersema, Peter D (1)
Clarke, Robert (1)
Andrulis, Irene L. (1)
Benitez, Javier (1)
Chenevix-Trench, Geo ... (1)
Daly, Mary B. (1)
Lambrechts, Diether (1)
Easton, Douglas F. (1)
Pharoah, Paul D. P. (1)
Garcia-Closas, Monts ... (1)
Ye, Weimin (1)
Kumar, Ashok (1)
Zhao, Wei (1)
Ahmad, Tariq (1)
Chetrit, Angela (1)
Cohn, Jay N (1)
Borg, Åke (1)
Brest, Patrick (1)
Simon, Hans-Uwe (1)
Mograbi, Baharia (1)
visa färre...
Lärosäte
Lunds universitet (12)
Göteborgs universitet (3)
Karolinska Institutet (3)
Umeå universitet (1)
Uppsala universitet (1)
Örebro universitet (1)
visa fler...
Linköpings universitet (1)
Chalmers tekniska högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (16)
Forskningsämne (UKÄ/SCB)
Samhällsvetenskap (8)
Medicin och hälsovetenskap (7)
Naturvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy